Concepts (81)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Contraceptive Agents | 3 | 2021 | 151 | 1.020 |
Why?
|
| Progestins | 1 | 2021 | 306 | 0.660 |
Why?
|
| Sterilization, Reproductive | 1 | 2018 | 21 | 0.650 |
Why?
|
| Contraception | 3 | 2017 | 359 | 0.630 |
Why?
|
| Pregnancy, Unplanned | 1 | 2017 | 95 | 0.560 |
Why?
|
| Postpartum Period | 2 | 2018 | 1086 | 0.500 |
Why?
|
| Uterine Artery Embolization | 1 | 2014 | 62 | 0.460 |
Why?
|
| Varicose Veins | 1 | 2014 | 154 | 0.420 |
Why?
|
| Cervix Uteri | 1 | 2014 | 590 | 0.360 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2014 | 500 | 0.340 |
Why?
|
| Abortion, Induced | 4 | 2022 | 458 | 0.340 |
Why?
|
| Medicaid | 1 | 2018 | 2737 | 0.250 |
Why?
|
| Menorrhagia | 1 | 2001 | 63 | 0.190 |
Why?
|
| Electrocoagulation | 1 | 2001 | 158 | 0.190 |
Why?
|
| Nonprescription Drugs | 1 | 2021 | 116 | 0.180 |
Why?
|
| Mifepristone | 2 | 2015 | 150 | 0.170 |
Why?
|
| Misoprostol | 2 | 2015 | 95 | 0.170 |
Why?
|
| Anticonvulsants | 1 | 2008 | 1916 | 0.150 |
Why?
|
| Dilatation and Curettage | 1 | 2015 | 56 | 0.130 |
Why?
|
| Postnatal Care | 1 | 2016 | 236 | 0.120 |
Why?
|
| Pregnancy Trimester, Second | 2 | 2015 | 732 | 0.120 |
Why?
|
| Epilepsy | 1 | 2008 | 3310 | 0.100 |
Why?
|
| Endometrial Neoplasms | 1 | 2001 | 1351 | 0.100 |
Why?
|
| Contraceptive Agents, Female | 2 | 2016 | 135 | 0.100 |
Why?
|
| Pregnancy | 6 | 2022 | 29144 | 0.090 |
Why?
|
| Abortifacient Agents, Nonsteroidal | 2 | 2015 | 62 | 0.080 |
Why?
|
| Contraceptive Devices, Female | 1 | 2008 | 43 | 0.080 |
Why?
|
| Drug Implants | 1 | 2008 | 244 | 0.070 |
Why?
|
| Diabetes, Gestational | 1 | 2016 | 1184 | 0.070 |
Why?
|
| Menstruation Disturbances | 1 | 2008 | 148 | 0.070 |
Why?
|
| Menstruation | 1 | 2008 | 302 | 0.070 |
Why?
|
| Pregnancy Outcome | 1 | 2015 | 2795 | 0.060 |
Why?
|
| Ovulation Inhibition | 1 | 2004 | 4 | 0.060 |
Why?
|
| Female | 12 | 2022 | 380200 | 0.060 |
Why?
|
| Young Adult | 3 | 2021 | 56434 | 0.060 |
Why?
|
| Decision Making | 1 | 2018 | 3888 | 0.060 |
Why?
|
| Prevalence | 1 | 2021 | 15221 | 0.060 |
Why?
|
| Adult | 9 | 2021 | 214056 | 0.060 |
Why?
|
| Medroxyprogesterone Acetate | 1 | 2004 | 163 | 0.060 |
Why?
|
| Drug Interactions | 1 | 2008 | 1460 | 0.060 |
Why?
|
| Abortifacient Agents, Steroidal | 1 | 2002 | 19 | 0.050 |
Why?
|
| Search Engine | 1 | 2022 | 144 | 0.050 |
Why?
|
| Time Factors | 2 | 2018 | 40077 | 0.040 |
Why?
|
| Humans | 12 | 2022 | 744376 | 0.040 |
Why?
|
| Risk Assessment | 2 | 2017 | 23336 | 0.040 |
Why?
|
| Policy | 1 | 2022 | 508 | 0.040 |
Why?
|
| Administration, Intravaginal | 2 | 2008 | 150 | 0.030 |
Why?
|
| Patient Dropouts | 1 | 2016 | 421 | 0.030 |
Why?
|
| Adolescent | 2 | 2021 | 85784 | 0.030 |
Why?
|
| Glucose Tolerance Test | 1 | 2016 | 1150 | 0.030 |
Why?
|
| Child | 1 | 2021 | 77708 | 0.030 |
Why?
|
| Surgical Instruments | 1 | 2015 | 395 | 0.030 |
Why?
|
| United States | 1 | 2018 | 69869 | 0.020 |
Why?
|
| Risk Factors | 1 | 2017 | 72295 | 0.020 |
Why?
|
| Middle Aged | 2 | 2021 | 213388 | 0.020 |
Why?
|
| Follow-Up Studies | 3 | 2015 | 39052 | 0.020 |
Why?
|
| Internet | 1 | 2022 | 3064 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2022 | 3529 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2015 | 2250 | 0.020 |
Why?
|
| Double-Blind Method | 2 | 2015 | 12025 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2015 | 8642 | 0.010 |
Why?
|
| Injections, Intramuscular | 1 | 2004 | 552 | 0.010 |
Why?
|
| Injections, Subcutaneous | 1 | 2004 | 667 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2015 | 63115 | 0.010 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2004 | 744 | 0.010 |
Why?
|
| Logistic Models | 1 | 2016 | 13409 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 2004 | 1591 | 0.010 |
Why?
|
| Prospective Studies | 3 | 2015 | 53291 | 0.010 |
Why?
|
| Progesterone | 1 | 2004 | 775 | 0.010 |
Why?
|
| Nausea | 1 | 2002 | 674 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2002 | 1797 | 0.010 |
Why?
|
| Patient Compliance | 1 | 2008 | 2685 | 0.010 |
Why?
|
| Estrogens | 1 | 2004 | 1566 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2004 | 4933 | 0.010 |
Why?
|
| Patient Satisfaction | 1 | 2008 | 3395 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2002 | 3914 | 0.010 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2008 | 3020 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2016 | 11725 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2001 | 77459 | 0.010 |
Why?
|
| Age Factors | 1 | 2004 | 18373 | 0.000 |
Why?
|
| Body Mass Index | 1 | 2004 | 12720 | 0.000 |
Why?
|
Concepts
(81)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(23)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_